2019•Cancer GeneticsRequires access

43. Considerations for implementation of the new ASCO/CAP guidelines for HER2 testing in the clinical laboratory

Gloria Haskell, Caron D. Glotzbach, Sonya Faulk, Angela Sanders-Cliette, Maria Gallego Attis, Stuart H. Schwartz, Jim H. Tepperberg

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Human Epidermal Growth Factor Receptor 2, Clinical Oncology, Fish <Actinopterygii>, Medicine, Oncology, Internal medicine, Breast cancer, Concomitant